Protocol No.: COG-ACNS1721

Title
COG-ACNS1721 - A Phase 2 Study of Veliparib (ABT-888, IND # 139199) and Local Irradiation, Followed by Maintenance Veliparib and Temozolomide, in Patients with Newly Diagnosed High-Grade Glioma (HGG) without H3 K27M or BRAFV600E Mutations
Principal Investigator
Paul, Stephan
Phase
II
Age Group
Both
Applicable Disease Site
Brain Cancer
Participating Institution
Mary Babb Randolph Cancer Center
Contacts
Jan Rapp
Clinical Trials Manager
Phone: +1 304-293-1229
Carla Corbin, RN, BSN
Nurse Clinician
Phone: +1 304-293-1217
April Shay, MSN, PNP-BC
Nurse Practitioner
Phone: +1 304-293-1217
Denise Casino
Clinical Trials Manager
Phone: +1 304-293-0735

View on ClinicalTrials.gov